DP-m300 series

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDP-m300 series
Drug Alias NameDP-242/3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBrain DiseasesBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesD-Pharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesD-Pharm Ltd
Active IndicationsN/A
Inactive IndicationsBrain DiseasesBrain Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A